We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+35.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$717B
AUM Growth
+$72.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
493
New
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1 +$5.33B
2 +$2.3B
3 +$1.99B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.79B
5
SPCX
SpaceX
SPCX
+$1.77B

Top Sells

Rank Stock Value
1 +$3.84B
2 +$3.37B
3 +$2.44B
4
MDT icon
Medtronic
MDT
+$2.31B
5
CNQ icon
Canadian Natural Resources
CNQ
+$2.2B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Consumer Discretionary 12.68%
3 Healthcare 10.77%
4 Communication Services 10.15%
5 Industrials 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
26
Mastercard
MA
$503B
$5.97B 0.83%
11,626,317
-2,258,265
HD icon
27
Home Depot
HD
$337B
$5.93B 0.83%
16,802,396
+1,816,088
ORCL icon
28
Oracle
ORCL
$411B
$5.82B 0.81%
39,746,237
+7,606,983
PGR icon
29
Progressive
PGR
$120B
$5.8B 0.81%
26,549,107
+3,974,965
MELI icon
30
Mercado Libre
MELI
$90.2B
$5.33B 0.74%
3,138,040
+420,868
APH icon
31
Amphenol
APH
$197B
$5.2B 0.73%
29,487,845
+2,857,216
D icon
32
Dominion Energy
D
$60.3B
$5.04B 0.7%
73,855,890
+24,879,843
TSM icon
33
TSMC
TSM
$2.14T
$5B 0.7%
10,474,198
+484,526
NFLX icon
34
Netflix
NFLX
$324B
$4.91B 0.68%
68,701,246
+655,265
UNP icon
35
Union Pacific
UNP
$177B
$4.65B 0.65%
17,112,417
+206,008
CNQ icon
36
Canadian Natural Resources
CNQ
$102B
$4.59B 0.64%
116,067,730
-48,364,929
XOM icon
37
ExxonMobil
XOM
$681B
$4.56B 0.64%
33,342,063
-359,411
MU icon
38
Micron Technology
MU
$1.06T
$4.42B 0.62%
3,827,473
-328,786
UNH icon
39
UnitedHealth
UNH
$354B
$4.38B 0.61%
10,534,177
-6,578,041
BLK icon
40
Blackrock
BLK
$179B
$4.29B 0.6%
4,458,212
-152,206
MO icon
41
Altria Group
MO
$109B
$4.22B 0.59%
58,653,624
+32,973,712
STX icon
42
Seagate
STX
$205B
$4.18B 0.58%
4,326,781
-1,409,289
CVNA icon
43
Carvana
CVNA
$71.5B
$4.17B 0.58%
63,423,386
+9,170,861
TDG icon
44
TransDigm Group
TDG
$68.2B
$4.16B 0.58%
3,119,490
-24,019
MDLZ icon
45
Mondelez International
MDLZ
$80B
$4.03B 0.56%
69,663,227
+1,359,061
MS icon
46
Morgan Stanley
MS
$342B
$3.78B 0.53%
18,070,606
-2,200,114
TSLA icon
47
Tesla
TSLA
$1.33T
$3.57B 0.5%
8,499,204
-125,609
ABT icon
48
Abbott
ABT
$195B
$3.35B 0.47%
36,908,990
-12,866,372
CNP icon
49
CenterPoint Energy
CNP
$26.7B
$3.14B 0.44%
71,382,073
-893,811
APD icon
50
Air Products & Chemicals
APD
$67.5B
$3.11B 0.43%
10,602,157
+191,647

Similar funds

Capital Research Global Investors's Q2 2026 Portfolio in Review

As of Q2 2026, Capital Research Global Investors held 493 positions worth $717B, up 11% from $645B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Capital Research Global Investors's Q2 2026 filing shows 33 new, 171 increased, 216 reduced and 67 closed positions. Its largest new stake was SpaceX: 10,438,223 shares worth $1.78B. The largest sale was Eli Lilly, an estimated $3.84B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Capital Research Global Investors's largest Q2 2026 buy was SpaceX: 10,438,223 shares worth $1.78B.
  • Capital Research Global Investors added most to Meta Platforms (Facebook) in Q2 2026, an estimated $5.33B increase.
  • Capital Research Global Investors's biggest Q2 2026 reduction was Eli Lilly, cutting an estimated $3.84B.
  • Capital Research Global Investors fully exited Charter Communications in Q2 2026, selling an estimated $1.14B.
  • Capital Research Global Investors's ten largest holdings make up 37% of its $717B portfolio in Q2 2026.
  • Capital Research Global Investors opened 33 new positions and closed 67 in Q2 2026.
  • Capital Research Global Investors's portfolio value rose 11% quarter-over-quarter to $717B.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.